
---
title: '为何北京迟迟不批准西方mRNA疫苗 两大原因曝光'
categories: 
 - 新媒体
 - 快媒体
 - 首页更新
headimg: 'https://www.kuai.media/news/2021/12/14/static/image/kuai/external-link.gif'
author: 快媒体
comments: false
date: 2021-12-14 04:10:53
thumbnail: 'https://www.kuai.media/news/2021/12/14/static/image/kuai/external-link.gif'
---

<div>   
<a href="https://www.kuai.media/go.php?aid=315853" target="_blank" role="link" data-focusable="true" class="sum" rel=" noopener noreferrer">

<strong>摘要</strong>: There is still no word from Chinese officials on when -- or whether – the BioNTech mRNA vaccine will ever be approved, even as the Omicron variant is detected in China. Analysis by @Nectar_Gan and @steve0george. https://t.co/AbVCsUwalfmdash; CNN Asia Pacific (@cnnasiapr) December 14, 2021今年夏天时，高传染性的Delta病毒席捲中国，部分公卫专家希望中国能采用高效的mRNA疫苗BioNTech，根据BioNTech的中国合作商复星表示，7月份该疫苗已通过监管，处于行政审查阶段，没想到5个月后，疫苗仍没有下落，如今Omicron袭来，专家对此感到担忧。《CNN》报导，中国大部分人接种的是国药和科兴等灭活疫苗，但功效远低于mRN ... <span class="more"><img width="35" src="https://www.kuai.media/news/2021/12/14/static/image/kuai/external-link.gif" referrerpolicy="no-referrer">点击阅读全文 @backchina.com</span>
</a>


  
</div>
            